|
|
|
|
|
|
| Open:
|
0.16 |
|
Volume:
|
3 |
| High:
|
0.16 |
|
52Wk High:
|
2.00 |
| Low:
|
0.16 |
|
52Wk Low:
|
0.05 |
|
|
|
|
|
|
|
|
|
|
|
10940 Wilshire Boulevard
Los Angeles, CA 90024, US
|
|
In Vitro and In Vivo Diagnostic Substances |
| |
|
|
|
 |
 |
|
 |
|
Free Registration enables all site features including Email Alerts, RSS Feeds, Charts & Reports, SEC Filings, and Executive & Company Profiles.
|
 |
 |
 |
 |
|
|
 |
|
 |
|
|
|
|
Board Member Report includes all current and historical board members, their board committees, whether they are the chair of each committee, the date they became a member of the board and their Job Title if they are also an executive of the firm. Also, you can create an email alert for any board member right from the Board Member report!
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SEC filings are made available through
SECFilings.com – our free SEC filings portal with e-mail alert
and RSS capabilities. Clicking on the links to the left will bring you to the
corresponding page on SECFilings.com where you can login with your
ExecutiveDisclosure.com username and password to instantly view filings and
setup e-mail or RSS alerts.
|
|
 |
 |
 |
|
|
|
|
Company Average Compensation vs. Average Compensation for all Same Market Cap Companies in Same Industry chart compares the average pay for the company against all companies in the same industry and market cap using actual dollar figures.
|
|
|
|
|
|
 |
|
 |
|
|
 |
|
|
|
|
Company Average Compensation vs. Industry Average Compensation chart compares the average pay for the company against all companies in the same industry using actual dollar figures, making it easy to see how the current company's compensation practices compare against the industry average.
|
|
|
|
|
|
|
|
|
|
|
|
Company Average Compensation % Trend vs. Company Stock Prices % Trend chart compares the year over year percentage change in the average compensation package against the year over year percentage change in the company's stock price.
|
|
|
|
|
|
 |
|
|
 |
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| BARRETT EVANS has been our director since July 15, 2004. Mr. Evans is eFund Capital Partner's Managing Partner. In 1990, Mr. Evans started his career with Cruttenden Roth, a regional emerging growth focused investment bank. At Cruttenden, Mr. Evans... (Read
more) |
|
09/08/2008
07/15/2004
|
|
|
|
|
| |
|
|
|
|
| Douglas C. Lane, currently is the President and Founder of Experigen Management Company, which provides professional management and interim senior executive management services to small cap and micro cap public and private technology and... (Read
more) |
|
221700.00 |
|
|
|
|
| |
|
|
|
|
| Mr. Jeffrey Conrad, has been a director of ours since June of 2007 and currently serves as the Secretary of the Company. Mr. Conrad is a securities attorney and partner in eFund Capital Management, LLC. He has accumulated successful experience in... (Read
more) |
|
06/29/2007
|
|
|
|
|
| |
|
|
|
|
| Mr. Robert Lutz, has spent most of the last 30 years as a senior executive officer, founder and private investor in several companies. Prior to his retirement, Mr. Lutz had a successful career in industrial engineering and was with The General... (Read
more) |
|
05/03/2007
|
|
|
|
|
| |
|
|
|
|
| Mr. Victor Voebel, Jr., since retiring from executive positions, well over 10 years ago, has acted as a private investor in companies. Mr. Voebel received a BBA from Southwest Texas State University in 1970 and then spent the next 20 years a senior... (Read
more) |
|
05/03/2007
|
|
|
|
|
| |
|
|
|
|
| Barrett Evans, has been a director of ours since June of 2007. Mr. Evans is eFund Capital Management"s managing partner. He began his career with Cruttenden Roth, a California regional emerging growth focused investment bank. He has significant... (Read
more) |
|
06/29/2007
|
|
|
|
|
| |
|
|
|
|
| Mr. Jeffrey Conrad, has been a director of ours since June of 2007 and currently serves as the Secretary of the Company. Mr. Conrad is a securities attorney and partner in eFund Capital Management, LLC. He has accumulated successful experience in... (Read
more) |
|
06/29/2007
|
|
|
|
|
| |
|
|
|
|
| Jonathan F. Atzen is our Senior Vice President and General Counsel. Mr. Atzen joined the company in 2005. Prior to joining the company, Mr. Atzen was an attorney at Heller Ehrman/Venture Law Group LLP and worked as a corporate/securities attorney... (Read
more) |
|
398537.00 |
|
|
|
|
| |
|
|
|
|
| T.J. Lou McKinney, CA. was first appointed a Director of the Company in August 2000 and assumed the position of Chief Financial Officer in 2001. In addition to his positions at Genesis Bioventures, he serves as President of No. 134 Corporate... (Read
more) |
|
2001
08/2000
|
|
|
|
|
| |
|
|
|
|
| Antony S. Dyakowski is a Director of the Company and has been actively involved with Genesis Bioventures since its inception. Mr. Dyakowski was appointed as a Director and agreed to Chair the Company's audit committee on May 1, 2005 when filling the... (Read
more) |
|
05/01/2005
|
|
|
|
|
| |
|
|
|
|
| Douglas C. Lane, currently is the President and Founder of Experigen Management Company, which provides professional management and interim senior executive management services to small cap and micro cap public and private technology and... (Read
more) |
|
221700.00 |
|
|
|
|
| |
|
|
|
|
| Mr. Robert Lutz, has spent most of the last 30 years as a senior executive officer, founder and private | | | |